Definitive Contract 75N92020C00005

Award Date 5/1/20
Potential Completion Date 4/30/25
Potential Value $3.3M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02118, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of 75N92025D00035|75N92025F00002, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Trustees of Boston University, doing business as Boston University Medical Campus. The contract is for the BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS (BHIPSC-LUNG) project, specifically for the IPSC TASK AREA B - SCIENTIFIC PROJECTS. The contract is a firm fixed-price delivery order with a ceiling...
This is a $8,803,200.00 cost-plus-award-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Precision For Medicine, Inc. The contract is for the maintenance of the NHLBI Biologic Specimen Repository, including the receipt, storage, tracking, preparation, and distribution of biological specimens for NHLBI research initiatives. It is a single-award Indefinite Delivery Contract (IDC) with a period of...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Trustees of Boston University, a private university, to provide analytical support services. The contract has a ceiling value of $79,654.00 and a period of performance ending on March 19, 2018. The contract was awarded on July 27, 2017 and is not set aside for any particular type of business. As a prime contractor, Boston...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,260,130 cost-plus-award-fee delivery order contract to Precision For Medicine, Inc. for the maintenance of the NHLBI Biologic Specimen Repository under Task Areas B and C. The contract has an ultimate completion date of March 31, 2026. This award is part of a larger $10.1 million single-award Indefinite Delivery Contract (IDC) that Precision For Medicine holds with NHLBI for maintaining the Biologic Specimen Repository from April...
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Trustees of Boston University, a private university located in Boston, Massachusetts. The contract is for $1,754,991.00 and is a definitive contract with a cost no fee pricing type. The contract is for biomedical (applied/exploratory) research and services, and has an ultimate completion date of April 30, 2010. The contract is not...
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to the Trustees of Boston University, a private non-profit university, for the Framingham Heart Study - Year 5 Exam. The $3,232,465.00 delivery order contract is for cost-no-fee work and does not have a set-aside designation. The contract is for the continuation of the longstanding Framingham Heart Study, a major epidemiological research...
This is a $4,635,483.00 fixed-price award fee task order issued by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The task order was awarded to Precision For Medicine, Inc., a for-profit organization that provides specialized scientific services to the pharmaceutical and life sciences industries, including biorepository management and biospecimen handling services for several NIH...
This $1,216,464 cost-plus-fixed-fee delivery order was awarded on May 10, 2024 by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Precision For Medicine, Inc. to provide maintenance services for the NHLBI Biologic Specimen Repository under Task Area B and Task Area C. The order has an ultimate completion date of April 30, 2025. Precision For Medicine, a for-profit biorepository management company, has extensive...
This federal contract award, with an ID of 75N92020A00003|75N92024F00043, was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. The award, valued at $122,097.24, is a Blanket Purchase Agreement (BPA) call to provide laboratory support services, including a laboratory technician, for the NHLBI's iPSC Core. The contract was awarded to Medical Science & Computing, LLC, a...
This is a $52,375 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to the Trustees of Boston University (doing business as Boston University Medical Campus). The contract is for "Mitochondrial Clonal Hematopoiesis of Indeterminate Potential (CHIP) Calling" research and services. The contract does not have a set-aside designation. Boston University is a leading private research...

This is a $3,250,000.00 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Trustees of Boston University (Boston University) to build and support a critical national biorepository of normal and lung disease-specific induced pluripotent stem cells (iPSCs) and their differentiated progeny. This contract supports the NHLBI's efforts to establish a sustainable resource to serve the lung research community. The contract was competitively awarded on May 1, 2020 with a period of performance through April 30, 2025. There was no set-aside designation for this requirement. As the incumbent provider, the National Disease Research Interchange would likely continue to support this biorepository work.

Generated 6/15/24, 9:21 AM